Heres an article summing up some of the research: Coronavirus and Rheumatoid Arthritis: What You Need To Know About COVID-19
Although there is currently no evidence to prove that patients with autoimmune disorders or on immunosuppressive drugs are at a greater risk of contracting the COVID infection, there remains a theoretical risk of increased complications in such patients if they acquire the infection . However, data from the COVID-19 Global Rheumatology Alliance Global Registry which gives live time information regarding rheumatic diseases and COVID-19 showed that as of on 17 August, 2020, the commonest rheumatic disease in which COVID-19 was documented was RA (694 patients out of 1783) . Based on a few other studies, rheumatoid arthritis seems to be the most common rheumatic disease in which COVID-19 infection has been documented [3, 5]. In a Chinese case series of 5 patients with rheumatic diseases who developed COVID-19, four of them had RA and one had systemic sclerosis. In another case series from New York, in which 86 patients with immune-mediated inflammatory diseases who contracted COVID-19 were studied, a high percentage of the admitted patients had RA .
"Managing rheumatoid arthritis during COVID-19 | SpringerLink
As I said in the post “In short we are not considered truly immunosuppressed but should act like we are.” If you are well controlled in your disease your OVERACTIVE immune system is tamped down. PsA as any of the rheumatoid disesase is not on the list of immunosuppresed conditions. (Kidney asthma, transplant etc.)our problem isn’t a depressed immune system but rather one that is soooooo active that the body can prevent antibody production. That doesn’t mean you should not be careful. For everyone of us that reports more infections colds flus etc the are among us many who report less because we through treatment have normalized our immune system. There is a risk of overdoing suppresion through treatment, but a far greater risk if we don’t treat. The need for vaccination and boosters is paramont. which is what the question was.